MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,043,930 | +115.6% | 69,879 | +78.8% | 0.00% | – |
| Q2 2023 | $1,411,744 | -36.6% | 39,074 | -34.7% | 0.00% | – |
| Q1 2023 | $2,225,000 | +114061.1% | 59,848 | +39.2% | 0.00% | – |
| Q4 2022 | $1,949 | -100.0% | 43,006 | -73.1% | 0.00% | -100.0% |
| Q3 2022 | $11,166,000 | +203.9% | 159,876 | +192.1% | 0.00% | +100.0% |
| Q2 2022 | $3,674,000 | +58.1% | 54,729 | +93.6% | 0.00% | – |
| Q1 2022 | $2,324,000 | -39.3% | 28,266 | +8.3% | 0.00% | – |
| Q4 2021 | $3,830,000 | -5.2% | 26,102 | +14.3% | 0.00% | – |
| Q3 2021 | $4,041,000 | -2.2% | 22,843 | -10.7% | 0.00% | – |
| Q2 2021 | $4,134,000 | -92.7% | 25,590 | -92.3% | 0.00% | -100.0% |
| Q1 2021 | $56,713,000 | -28.2% | 331,074 | -7.9% | 0.01% | -33.3% |
| Q4 2020 | $78,936,000 | +73.1% | 359,389 | +30.9% | 0.01% | +50.0% |
| Q3 2020 | $45,604,000 | +2362.4% | 274,644 | +1592.8% | 0.01% | – |
| Q2 2020 | $1,852,000 | +124.8% | 16,224 | +51.6% | 0.00% | – |
| Q1 2020 | $824,000 | -62.8% | 10,702 | -37.8% | 0.00% | – |
| Q4 2019 | $2,217,000 | +176.8% | 17,212 | +67.4% | 0.00% | – |
| Q3 2019 | $801,000 | -8.0% | 10,281 | +23.4% | 0.00% | – |
| Q2 2019 | $871,000 | +51.0% | 8,330 | +5.7% | 0.00% | – |
| Q1 2019 | $577,000 | +163.5% | 7,881 | +53.0% | 0.00% | – |
| Q4 2018 | $219,000 | -0.5% | 5,152 | +10.3% | 0.00% | – |
| Q3 2018 | $220,000 | +21.5% | 4,672 | +27.0% | 0.00% | – |
| Q2 2018 | $181,000 | +465.6% | 3,678 | +32.4% | 0.00% | – |
| Q3 2017 | $32,000 | -83.5% | 2,777 | -92.6% | 0.00% | – |
| Q1 2017 | $194,000 | -24.8% | 37,366 | -31.1% | 0.00% | – |
| Q4 2016 | $258,000 | +29.6% | 54,261 | +80.5% | 0.00% | – |
| Q3 2016 | $199,000 | -35.4% | 30,060 | -46.7% | 0.00% | – |
| Q2 2016 | $308,000 | -81.3% | 56,410 | -26.9% | 0.00% | – |
| Q1 2016 | $1,651,000 | -28.5% | 77,160 | +5.7% | 0.00% | -100.0% |
| Q4 2015 | $2,308,000 | -17.7% | 73,025 | -10.4% | 0.00% | 0.0% |
| Q3 2015 | $2,806,000 | +12.3% | 81,525 | +2.7% | 0.00% | 0.0% |
| Q2 2015 | $2,499,000 | -0.1% | 79,400 | -6.9% | 0.00% | 0.0% |
| Q1 2015 | $2,502,000 | +52.1% | 85,325 | -3.9% | 0.00% | – |
| Q4 2014 | $1,645,000 | +0.9% | 88,800 | -4.6% | 0.00% | – |
| Q3 2014 | $1,631,000 | – | 93,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |